Dechra Pharmaceuticals (LSE:DPH) FCF Yield % : 0.76 (As of Apr. 30, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Dechra Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Dechra Pharmaceuticals's Trailing 12-Month Free Cash Flow is £33.3 Mil, and Market Cap is £4,401.3 Mil. Therefore, Dechra Pharmaceuticals's FCF Yield % for today is 0.76%.

The historical rank and industry rank for Dechra Pharmaceuticals's FCF Yield % or its related term are showing as below:

LSE:DPH' s FCF Yield % Range Over the Past 10 Years
Min: -1.33 Med: 2.01 Max: 4.82
Current: 0.76

During the past 13 years, the highest FCF Yield % of Dechra Pharmaceuticals was 4.82%. The lowest was -1.33%. And the median was 2.01%.

LSE:DPH's FCF Yield % is not ranked
in the Drug Manufacturers industry.
Industry Median: -0.63 vs LSE:DPH: 0.76

Dechra Pharmaceuticals's FCF Margin % for the quarter that ended in Jun. 2023 was -1.20%.

Dechra Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Dechra Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dechra Pharmaceuticals FCF Yield % Chart

Dechra Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Yield %

Get a 7-Day Free Trial

2.10

1.86

-0.97

1.21

0.79

Dechra Pharmaceuticals Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Yield %	Get a 7-Day Free Trial															0.52	1.34	0.36	2.54	-0.22

Competitive Comparison of Dechra Pharmaceuticals's FCF Yield %

For the Drug Manufacturers - General subindustry, Dechra Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dechra Pharmaceuticals's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dechra Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Dechra Pharmaceuticals's FCF Yield % falls into.

Dechra Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Dechra Pharmaceuticals's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	33.3	/	4197.91168
	=	0.79%

Dechra Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-4.6	*	2	/	4197.91168
	=	-0.22%

Dechra Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Dechra Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Dechra Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dechra Pharmaceuticals (LSE:DPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dechra Pharmaceuticals PLC (LSE:DPH) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

DPHAY:USA DPHl:UK 1PK:Germany

Address

24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, GBR, CW9 7UA

Website

https://www.dechra.com

Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.

Dechra Pharmaceuticals (LSE:DPH) Headlines

No Headlines